Form 8-K - Current report:
SEC Accession No. 0001477932-24-001778
Filing Date
2024-04-02
Accepted
2024-04-02 16:05:26
Documents
15
Period of Report
2024-04-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K upxi_8k.htm   iXBRL 8-K 25891
  Complete submission text file 0001477932-24-001778.txt   154464

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA upxi-20240402.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE upxi-20240402_lab.xml EX-101.LAB 15213
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE upxi-20240402_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE upxi-20240402_pre.xml EX-101.PRE 9640
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE upxi-20240402_def.xml EX-101.DEF 2099
18 EXTRACTED XBRL INSTANCE DOCUMENT upxi_8k_htm.xml XML 4007
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40535 | Film No.: 24814159
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)